Sign in Subscribe
Drugs

Recent Advances in Cancer Research at Ohio State University, U.S.

Strategic Insights

— 1 min read

Researchers at Ohio State University have made significant strides in cancer research, focusing on various aspects of the disease, including cancer therapy, hereditary nonpolyposis colorectal cancer (HNPCC) syndrome, and the impact of cigarette smoking on colorectal polyp recurrence. These studies aim to improve our understanding of cancer and develop effective treatments for this complex disease.

Key Takeaways:

  • Researchers have developed small-molecule cyclin D1-ablative agents, such as STG28, which have shown promise in cancer therapy by inhibiting the proliferation of MCF-7 breast cancer cells and ablating cyclin D1 with high specificity. (Journal of Medicinal Chemistry, 2006)
  • The risk of cancer in HNPCC syndrome was re-examined using a comprehensive data set from a geographically defined region. The study found that the lifetime risk for colorectal cancer was 68.7% for men and 52.2% for women, suggesting a need to alter counseling practices and consider HNPCC in older individuals than before. (Gastroenterology, 2005)
  • Cigarette smoking was linked to an increased risk of hyperplastic polyps, particularly distal and rectal hyperplastic polyps, and was associated with the development of multiple and small-sized hyperplastic polyps. (Cancer Causes & Control, 2005)
  • The association between cigarette smoking and colorectal polyp recurrence was investigated prospectively, and the study found that smoking was significantly associated with the development of hyperplastic polyps, except for those in the proximal colon. (Cancer Causes & Control, 2005)
  • Researchers have highlighted the importance of considering HNPCC in older individuals and adjusting counseling practices accordingly, given the lower lifetime cancer risks for CRC and endometrial cancer than previously assumed.

Statistics:

  • The median age at diagnosis of CRC in HNPCC families was 61.2 years (CI, 56.3-68.0 y).
  • The lifetime risk for CRC was 68.7% (CI, 58.6%-78.9%) for men and 52.2% (CI, 37.6%-66.9%) for women.
  • The median age at diagnosis of CRC in probands was 44.0 years (CI, 41.0-46.3 y).
  • The median age of onset for endometrial cancer (EC) was 62.0 years (CI, 55.9 y).
  • Cigarette smoking was significantly associated with the development of hyperplastic polyps in 31.3% of participants (95% CI, 26.6-36.3).

Sources:

  • Journal of Medicinal Chemistry, 2006;49(15):4684-4689.
  • Gastroenterology, 2005;129(2):415-421.
  • Cancer Causes & Control, 2005;16(9):1021-1033.

Read more